GWAAIS 2022 Academic Conference Series - May

May 18, 2022

Lecture will be focused on mast cell activation syndrome.  This is a disease with multiple symptoms involving different organ systems which can be difficult to diagnose and challenging to manage and treat.
 

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists, fellows- in- training in allergy and immunology, primary care physicians, and allied health care providers in the field of allergy and immunology.

Learning Objectives

Upon completion of this activity, participants should be able to:
Appropriately diagnose atopic dermatitis. Actively manage and treat atopic dermatitis using medical and topical therapeutics. Actively manage and treat atopic dermatitis using immunomodulating therapies to include monoclonal antibodies.

 

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include:

Ambulatory procedure centers

  • Blood banks
  • Diagnostic labs that do not sell proprietary products
  • Electronic health records companies
  • Government or military agencies
  • Group medical practices
  • Health law firms
  • Health profession membership organizations
  • Hospitals or healthcare delivery systems
  • Infusion centers
  • Insurance or managed care companies
  • Nursing homes
  • Pharmacies that do not manufacture proprietary compounds
  • Publishing or education companies
  • Rehabilitation centers
  • Schools of medicine or health science universities
  • Software or game developers

 

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified conflicts of interest have been mitigated

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Attendance
Course opens: 
05/18/2022
Course expires: 
05/17/2024
Event starts: 
05/18/2022 - 7:15pm CDT
Event ends: 
05/18/2022 - 8:30pm CDT
Rating: 
0

Greater Washington Allergy, Asthma and Immunology Society

Second Academic Conference Series 2022

May 18, 2022
The Hilton McLean Tysons Corner | 7920 Jones Branch Drive, McLean, Virginia| (703) 847-5000

 

AGENDA
 

6:00pm-7:00pm                                                Exhibits | Registration | Reception

 

7:00pm-7:15pm                                                Welcome & Introduction

Theodore T. Kim, MD – President, GWAAIS

 

7:15pm-8:15pm                                    “Updates on Atopic Dermatitis”

Speaker:  Dr. Donald Leung, Division Head, Pediatric Allergy & Immunology

National Jewish Health

 

8:15pm-8:30pm                                                Questions and Answer Session.

 

8:30pm                                                              Adjourn.

Donald Leung, MD, speaker
Consultant: Boehringer Ingelheim, Genentech, Leo Pharma, Incyte
Researcher: Sanofi Genzyme

Theodore Kim, MD, planner
No relevant financial relationships to disclose

 Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the Greater Washington Allergy, Asthma and Immunology Society (GWAAIS).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation

The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 In compliance with the Americans with Disabilities Act, GWAAIS requests that any participant in need of accommodation contact Kay Kim, email: GWAAISDMV@gmail.com

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Attendance
Please login or create an account to take this course.